Rheumatology News Roundup: 3 Things to Know

February 26, 2018
Mark L. Fuerst

Highlights of 3 recent studies that can affect your practice: a novel procedure for knee pain, cardiovascular risk in RA, and febuxostat in early gout.

References:1. Davis T, Loudermilk E, DePalma M, et al. Prospective, multicenter, randomized, crossover clinical trial comparing the safety and effectiveness of cooled radiofrequency ablation with corticosteroid injection in the management of knee pain from osteoarthritis. Reg Anesth Pain Med. 2018;43:84-91. doi: 10.1097/AAP.0000000000000690.2. Curtis JR, Xie F, Chen L, et al. Biomarker-related risk for myocardial infarction and serious infections in patients with rheumatoid arthritis: a population-based study. Ann Rheum Dis. 2017 Dec 21. doi: 10.1136/annrheumdis-2017-211727.3. Dalbeth N, et al. Effects of febuxostat in early gout. Arthritis Rheumatol. 2017;69:2386-2395. doi:10.1002/art.40233